
Medixone S 1000mg/500mg Injection
Marketer
Valcret Lifesciences Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Medixone S 1000mg/500mg Injection
Combix 1000mg/500mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration must be overseen by a medical professional. Consistent adherence to the prescribed schedule is crucial; complete the entire course, regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should seek medical advice prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your doctor might order laboratory tests to monitor therapeutic response.
Primary Ingredients of Medixone S 1000mg/500mg Injection
No text provided to rephrase.
Uses of Medixone S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Medixone S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Medixone S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Medixone S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Medixone S 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Medixone S 1000mg/500mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to survive. Sulbactam, a beta-lactamase inhibitor, complements this action by counteracting bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Medixone S 1000mg/500mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
Employing Medixone S 1000mg/500mg Injection during pregnancy is typically deemed safe. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Medixone S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Medixone S 1000mg/500mg Injection could induce drowsiness, blurred vision, or dizziness. Refrain from driving if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Medixone S 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
The injectable formulation of Medixone S (1000mg/500mg) requires careful administration in individuals with advanced hepatic impairment. Dosage modification may be necessary; physician consultation is advised. Altering the dose of Medixone S (1000mg/500mg) injection is unnecessary for those with less severe liver conditions.
What if you forget to take Medixone S 1000mg/500mg Injection :
Omitting a scheduled dose of Medixone S 1000mg/500mg Injection warrants immediate physician consultation.
Facts to Know About Medixone S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
